25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANIKA THERAPEUTICS (AKP.SG)
Buy, Hold or Sell?

Let's analyze ANIKA THERAPEUTICS (AKP.SG) together

I guess you are interested in ANIKA THERAPEUTICS (AKP.SG). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ANIKA THERAPEUTICS (AKP.SG). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ANIKA THERAPEUTICS (AKP.SG)

I send you an email if I find something interesting about ANIKA THERAPEUTICS (AKP.SG).

1. Quick Overview

1.1. Quick analysis of ANIKA THERAPEUTICS (AKP.SG) (30 sec.)










1.2. What can you expect buying and holding a share of ANIKA THERAPEUTICS (AKP.SG)? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€11.28
Expected worth in 1 year
€5.53
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
€-5.75
Return On Investment
-39.6%

For what price can you sell your share?

Current Price per Share
€14.50
Expected price per share
€14.70 - €17.10
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of ANIKA THERAPEUTICS (AKP.SG) (5 min.)




Live pricePrice per Share (EOD)
€14.50
Intrinsic Value Per Share
€5.45 - €6.66
Total Value Per Share
€16.73 - €17.94

2.2. Growth of ANIKA THERAPEUTICS (AKP.SG) (5 min.)




Is ANIKA THERAPEUTICS (AKP.SG) growing?

Current yearPrevious yearGrowGrow %
How rich?$179.8m$276.9m-$74.1m-36.6%

How much money is ANIKA THERAPEUTICS (AKP.SG) making?

Current yearPrevious yearGrowGrow %
Making money-$24.3m-$6.1m-$18.2m-74.8%
Net Profit Margin-58.8%-15.4%--

How much money comes from the company's main activities?

2.3. Financial Health of ANIKA THERAPEUTICS (AKP.SG) (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of ANIKA THERAPEUTICS (AKP.SG)?

Welcome investor! ANIKA THERAPEUTICS (AKP.SG)'s management wants to use your money to grow the business. In return you get a share of ANIKA THERAPEUTICS (AKP.SG).

First you should know what it really means to hold a share of ANIKA THERAPEUTICS (AKP.SG). And how you can make/lose money.

Speculation

The Price per Share of ANIKA THERAPEUTICS (AKP.SG) is €14.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ANIKA THERAPEUTICS (AKP.SG).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ANIKA THERAPEUTICS (AKP.SG), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.28. Based on the TTM, the Book Value Change Per Share is €-1.44 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ANIKA THERAPEUTICS (AKP.SG).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-2.04-14.0%-1.66-11.5%-0.42-2.9%-0.51-3.5%-0.44-3.0%
Usd Book Value Change Per Share-1.93-13.3%-1.56-10.8%-0.26-1.8%0.614.2%0.614.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.93-13.3%-1.56-10.8%-0.26-1.8%0.614.2%0.614.2%
Usd Price Per Share24.10-24.37-25.86-30.45-26.48-
Price to Earnings Ratio-2.96--278.56--19.43--47.64--41.42-
Price-to-Total Gains Ratio-12.46-41.86-312.21-40.31-40.31-
Price to Book Ratio1.97-1.78-1.37-1.66-1.44-
Price-to-Total Gains Ratio-12.46-41.86-312.21-40.31-40.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.73975
Number of shares63
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.560.61
Usd Total Gains Per Share-1.560.61
Gains per Quarter (63 shares)-98.2638.56
Gains per Year (63 shares)-393.04154.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-393-4030154144
20-786-7960308298
30-1179-11890463452
40-1572-15820617606
50-1965-19750771760
60-2358-23680925914
70-2751-2761010801068
80-3144-3154012341222
90-3537-3547013881376
100-3930-3940015421530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%5.015.00.025.0%5.015.00.025.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.020.00.0%0.00.020.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ANIKA THERAPEUTICS (AKP.SG) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.782-1.437-19%-0.237-87%0.564-416%0.564-416%
Book Value Per Share--11.27612.658-11%17.395-35%16.977-34%14.763-24%
Current Ratio--5.3395.529-3%5.934-10%6.161-13%7.808-32%
Debt To Asset Ratio--0.2230.212+5%0.176+26%0.210+6%0.199+12%
Debt To Equity Ratio--0.2870.269+7%0.214+34%0.271+6%0.254+13%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--278727230.800281237780.100-1%294734348.000-5%339482959.680-18%339482959.680-18%
Eps---1.876-1.530-18%-0.386-79%-0.466-75%-0.405-78%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--1.9521.864+5%1.974-1%2.523-23%2.523-23%
Free Cash Flow Per Share--0.201-0.021+110%-0.173+186%0.046+334%0.046+334%
Free Cash Flow To Equity Per Share---0.050-0.131+164%-0.267+439%-0.044-11%-0.044-11%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.660--------
Intrinsic Value_10Y_min--5.451--------
Intrinsic Value_1Y_max---0.083--------
Intrinsic Value_1Y_min---0.082--------
Intrinsic Value_3Y_max--0.322--------
Intrinsic Value_3Y_min--0.296--------
Intrinsic Value_5Y_max--1.417--------
Intrinsic Value_5Y_min--1.266--------
Market Cap--326206800.000331312600.000-2%349451325.000-7%406372305.000-20%353367221.739-8%
Net Profit Margin---0.772-0.588-24%-0.154-80%-0.188-76%-0.128-83%
Operating Margin----0%-0%0.009-100%0.059-100%
Operating Ratio--2.6061.723+51%1.575+65%1.574+66%1.486+75%
Pb Ratio1.286-53%1.9691.782+11%1.367+44%1.658+19%1.442+37%
Pe Ratio-1.933+35%-2.959-278.560+9314%-19.430+557%-47.638+1510%-41.425+1300%
Price Per Share14.500-53%22.20022.450-1%23.825-7%28.055-21%24.396-9%
Price To Free Cash Flow Ratio18.069-53%27.6650.677+3988%-17.839+164%37.912-27%32.967-16%
Price To Total Gains Ratio-8.139+35%-12.46041.856-130%312.206-104%40.308-131%40.308-131%
Quick Ratio--1.1121.173-5%1.277-13%1.292-14%2.221-50%
Return On Assets---0.129-0.095-27%-0.018-86%-0.026-80%-0.019-85%
Return On Equity---0.166-0.121-27%-0.022-87%-0.033-80%-0.025-85%
Total Gains Per Share---1.782-1.437-19%-0.237-87%0.564-416%0.564-416%
Usd Book Value--179857273.086202743167.122-11%276902643.454-35%267165207.648-33%267172746.496-33%
Usd Book Value Change Per Share---1.934-1.560-19%-0.257-87%0.612-416%0.612-416%
Usd Book Value Per Share--12.24013.741-11%18.882-35%18.429-34%16.025-24%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--302558409.033305283610.299-1%319934134.754-5%368508752.733-18%368508752.733-18%
Usd Eps---2.036-1.661-18%-0.418-79%-0.505-75%-0.439-78%
Usd Free Cash Flow--3199880.320-351986.835+111%-2765146.580+186%697323.919+359%1537812.049+108%
Usd Free Cash Flow Per Share--0.218-0.023+110%-0.188+186%0.050+334%0.050+334%
Usd Free Cash Flow To Equity Per Share---0.054-0.142+164%-0.290+439%-0.048-11%-0.048-11%
Usd Market Cap--354097481.400359639827.300-2%379329413.288-7%441117137.078-20%383580119.198-8%
Usd Price Per Share15.740-53%24.09824.369-1%25.862-7%30.454-21%26.481-9%
Usd Profit---29916881.067-24379088.188-19%-6143520.224-79%-7391873.534-75%-5421579.834-82%
Usd Revenue--38751550.63841040465.029-6%40826723.023-5%37604493.539+3%36388030.341+6%
Usd Total Gains Per Share---1.934-1.560-19%-0.257-87%0.612-416%0.612-416%
 EOD+4 -2MRQTTM+7 -28YOY+6 -295Y+6 -3010Y+6 -30

3.3 Fundamental Score

Let's check the fundamental score of ANIKA THERAPEUTICS (AKP.SG) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.933
Price to Book Ratio (EOD)Between0-11.286
Net Profit Margin (MRQ)Greater than0-0.772
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.112
Current Ratio (MRQ)Greater than15.339
Debt to Asset Ratio (MRQ)Less than10.223
Debt to Equity Ratio (MRQ)Less than10.287
Return on Equity (MRQ)Greater than0.15-0.166
Return on Assets (MRQ)Greater than0.05-0.129
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of ANIKA THERAPEUTICS (AKP.SG) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose14.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About ANIKA THERAPEUTICS (AKP.SG)

  • Other
  • 0

There is no Profile data available for AKP.SG.

Fundamental data was last updated by Penke on 2025-03-11 19:03:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit ANIKA THERAPEUTICS (AKP.SG) earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • A Net Profit Margin of -77.2% means that €-0.77 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is -77.2%. The company is making a huge loss. -2
  • The TTM is -58.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-77.2%TTM-58.8%-18.4%
TTM-58.8%YOY-15.4%-43.4%
TTM-58.8%5Y-18.8%-40.0%
5Y-18.8%10Y-12.8%-5.9%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-77.2%5.6%-82.8%
TTM-58.8%5.9%-64.7%
YOY-15.4%6.1%-21.5%
5Y-18.8%6.2%-25.0%
10Y-12.8%6.1%-18.9%
4.3.1.2. Return on Assets

Shows how efficient ANIKA THERAPEUTICS (AKP.SG) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • -12.9% Return on Assets means that ANIKA THERAPEUTICS (AKP.SG) generated €-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is -12.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.9%TTM-9.5%-3.4%
TTM-9.5%YOY-1.8%-7.7%
TTM-9.5%5Y-2.6%-6.9%
5Y-2.6%10Y-1.9%-0.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.9%1.3%-14.2%
TTM-9.5%1.1%-10.6%
YOY-1.8%1.3%-3.1%
5Y-2.6%1.3%-3.9%
10Y-1.9%1.3%-3.2%
4.3.1.3. Return on Equity

Shows how efficient ANIKA THERAPEUTICS (AKP.SG) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • -16.6% Return on Equity means ANIKA THERAPEUTICS (AKP.SG) generated €-0.17 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is -16.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.6%TTM-12.1%-4.5%
TTM-12.1%YOY-2.2%-9.9%
TTM-12.1%5Y-3.3%-8.8%
5Y-3.3%10Y-2.5%-0.8%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.6%3.7%-20.3%
TTM-12.1%3.4%-15.5%
YOY-2.2%3.9%-6.1%
5Y-3.3%3.9%-7.2%
10Y-2.5%3.8%-6.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ANIKA THERAPEUTICS (AKP.SG).

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient ANIKA THERAPEUTICS (AKP.SG) is operating .

  • Measures how much profit ANIKA THERAPEUTICS (AKP.SG) makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.9%-0.9%
5Y0.9%10Y5.9%-5.0%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-12.7%
TTM-8.2%-8.2%
YOY-7.8%-7.8%
5Y0.9%4.4%-3.5%
10Y5.9%6.8%-0.9%
4.3.2.2. Operating Ratio

Measures how efficient ANIKA THERAPEUTICS (AKP.SG) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 2.61 means that the operating costs are €2.61 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is 2.606. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.723. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.606TTM1.723+0.883
TTM1.723YOY1.575+0.148
TTM1.7235Y1.574+0.149
5Y1.57410Y1.486+0.088
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6061.313+1.293
TTM1.7231.355+0.368
YOY1.5751.375+0.200
5Y1.5741.324+0.250
10Y1.4861.381+0.105
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ANIKA THERAPEUTICS (AKP.SG).

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if ANIKA THERAPEUTICS (AKP.SG) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 5.34 means the company has €5.34 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is 5.339. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.529. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.339TTM5.529-0.190
TTM5.529YOY5.934-0.405
TTM5.5295Y6.161-0.632
5Y6.16110Y7.808-1.646
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3391.426+3.913
TTM5.5291.416+4.113
YOY5.9341.538+4.396
5Y6.1611.562+4.599
10Y7.8081.496+6.312
4.4.3.2. Quick Ratio

Measures if ANIKA THERAPEUTICS (AKP.SG) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • A Quick Ratio of 1.11 means the company can pay off €1.11 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is 1.112. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.173. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.112TTM1.173-0.060
TTM1.173YOY1.277-0.105
TTM1.1735Y1.292-0.119
5Y1.29210Y2.221-0.929
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1120.531+0.581
TTM1.1730.553+0.620
YOY1.2770.603+0.674
5Y1.2920.606+0.686
10Y2.2210.609+1.612
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ANIKA THERAPEUTICS (AKP.SG).

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of ANIKA THERAPEUTICS (AKP.SG) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to Other industry mean.
  • A Debt to Asset Ratio of 0.22 means that ANIKA THERAPEUTICS (AKP.SG) assets are financed with 22.3% credit (debt) and the remaining percentage (100% - 22.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is 0.223. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.212. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.212+0.011
TTM0.212YOY0.176+0.035
TTM0.2125Y0.210+0.002
5Y0.21010Y0.199+0.011
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.520-0.297
TTM0.2120.529-0.317
YOY0.1760.523-0.347
5Y0.2100.555-0.345
10Y0.1990.564-0.365
4.5.4.2. Debt to Equity Ratio

Measures if ANIKA THERAPEUTICS (AKP.SG) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • A Debt to Equity ratio of 28.7% means that company has €0.29 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The MRQ is 0.287. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.269. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.287TTM0.269+0.018
TTM0.269YOY0.214+0.054
TTM0.2695Y0.271-0.003
5Y0.27110Y0.254+0.017
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2871.095-0.808
TTM0.2691.128-0.859
YOY0.2141.155-0.941
5Y0.2711.338-1.067
10Y0.2541.429-1.175
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings ANIKA THERAPEUTICS (AKP.SG) generates.

  • Above 15 is considered overpriced but always compare ANIKA THERAPEUTICS (AKP.SG) to the Other industry mean.
  • A PE ratio of -2.96 means the investor is paying €-2.96 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The EOD is -1.933. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.959. Based on the earnings, the company is expensive. -2
  • The TTM is -278.560. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.933MRQ-2.959+1.026
MRQ-2.959TTM-278.560+275.601
TTM-278.560YOY-19.430-259.130
TTM-278.5605Y-47.638-230.922
5Y-47.63810Y-41.425-6.214
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-1.93314.089-16.022
MRQ-2.95913.537-16.496
TTM-278.56012.493-291.053
YOY-19.43011.191-30.621
5Y-47.63812.976-60.614
10Y-41.42513.175-54.600
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The EOD is 18.069. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 27.665. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 0.677. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD18.069MRQ27.665-9.595
MRQ27.665TTM0.677+26.988
TTM0.677YOY-17.839+18.516
TTM0.6775Y37.912-37.235
5Y37.91210Y32.967+4.945
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD18.0698.643+9.426
MRQ27.6658.169+19.496
TTM0.6777.139-6.462
YOY-17.8395.896-23.735
5Y37.9123.220+34.692
10Y32.9673.714+29.253
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of ANIKA THERAPEUTICS (AKP.SG) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 1.97 means the investor is paying €1.97 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of ANIKA THERAPEUTICS (AKP.SG):

  • The EOD is 1.286. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.969. Based on the equity, the company is underpriced. +1
  • The TTM is 1.782. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.286MRQ1.969-0.683
MRQ1.969TTM1.782+0.187
TTM1.782YOY1.367+0.415
TTM1.7825Y1.658+0.123
5Y1.65810Y1.442+0.216
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD1.2861.532-0.246
MRQ1.9691.404+0.565
TTM1.7821.428+0.354
YOY1.3671.405-0.038
5Y1.6581.718-0.060
10Y1.4421.715-0.273
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets231,405
Total Liabilities51,541
Total Stockholder Equity179,864
 As reported
Total Liabilities 51,541
Total Stockholder Equity+ 179,864
Total Assets = 231,405

Assets

Total Assets231,405
Total Current Assets136,106
Long-term Assets95,299
Total Current Assets
Cash And Cash Equivalents 62,368
Net Receivables 28,357
Inventory 39,629
Other Current Assets 5,752
Total Current Assets  (as reported)136,106
Total Current Assets  (calculated)136,106
+/-0
Long-term Assets
Property Plant Equipment 71,780
Goodwill 7,656
Intangible Assets 3,081
Long-term Assets Other 11,310
Long-term Assets  (as reported)95,299
Long-term Assets  (calculated)93,827
+/- 1,472

Liabilities & Shareholders' Equity

Total Current Liabilities25,493
Long-term Liabilities26,048
Total Stockholder Equity179,864
Total Current Liabilities
Accounts payable 6,805
Other Current Liabilities 378
Total Current Liabilities  (as reported)25,493
Total Current Liabilities  (calculated)7,183
+/- 18,310
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt27,534
Long-term Liabilities  (as reported)26,048
Long-term Liabilities  (calculated)27,534
+/- 1,486
Total Stockholder Equity
Retained Earnings 93,532
Total Stockholder Equity (as reported)179,864
Total Stockholder Equity (calculated)93,532
+/- 86,332
Other
Capital Stock147
Common Stock Shares Outstanding 14,694
Net Invested Capital 179,864
Net Working Capital 110,613
Property Plant and Equipment Gross 71,780



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
306,659
287,364
319,579
330,710
398,913
440,525
416,338
365,605
362,253
363,131
352,930
347,535
342,239
354,123
347,746
349,128
339,074
328,882
328,158
270,632
263,744
262,655
231,405
231,405262,655263,744270,632328,158328,882339,074349,128347,746354,123342,239347,535352,930363,131362,253365,605416,338440,525398,913330,710319,579287,364306,659
   > Total Current Assets 
209,695
189,924
223,817
234,306
161,126
221,283
201,875
177,383
173,474
177,761
165,780
168,528
165,322
167,856
167,761
169,547
160,331
152,201
156,778
163,309
158,962
155,000
136,106
136,106155,000158,962163,309156,778152,201160,331169,547167,761167,856165,322168,528165,780177,761173,474177,383201,875221,283161,126234,306223,817189,924209,695
       Cash And Cash Equivalents 
95,514
69,407
103,381
157,463
65,833
116,746
104,216
95,817
94,599
97,181
90,976
94,386
90,325
91,392
87,777
86,327
79,737
65,071
70,651
72,867
68,629
62,822
62,368
62,36862,82268,62972,86770,65165,07179,73786,32787,77791,39290,32594,38690,97697,18194,59995,817104,216116,74665,833157,463103,38169,40795,514
       Short-term Investments 
71,222
72,045
69,825
27,480
26,452
27,624
20,542
2,501
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002,50120,54227,62426,45227,48069,82572,04571,222
       Net Receivables 
18,265
23,073
23,889
23,079
28,101
24,094
23,009
24,102
26,509
29,426
32,352
29,843
29,313
32,172
34,168
34,627
30,629
36,737
34,682
35,961
32,077
33,773
28,357
28,35733,77332,07735,96134,68236,73730,62934,62734,16832,17229,31329,84332,35229,42626,50924,10223,00924,09428,10123,07923,88923,07318,265
       Inventory 
22,617
22,986
25,243
21,995
35,081
46,479
47,882
46,209
42,718
42,857
35,019
36,010
35,225
35,336
37,237
39,765
41,319
42,604
43,724
46,386
49,408
51,464
39,629
39,62951,46449,40846,38643,72442,60441,31939,76537,23735,33635,22536,01035,01942,85742,71846,20947,88246,47935,08121,99525,24322,98622,617
   > Long-term Assets 
96,964
97,440
95,762
96,404
237,787
219,242
214,463
188,222
188,779
185,370
187,150
179,007
176,917
186,267
179,985
179,581
178,743
176,681
171,380
107,323
104,782
107,655
95,299
95,299107,655104,782107,323171,380176,681178,743179,581179,985186,267176,917179,007187,150185,370188,779188,222214,463219,242237,78796,40495,76297,44096,964
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,377
78,975
78,978
77,619
74,990
74,965
74,238
75,450
71,780
71,78075,45074,23874,96574,99077,61978,97878,97578,37700000000000000
       Goodwill 
7,695
7,798
7,489
7,694
33,802
33,958
32,419
8,413
8,045
8,149
7,950
7,781
7,625
7,169
6,721
7,339
7,462
7,467
7,253
7,571
7,403
7,350
7,656
7,6567,3507,4037,5717,2537,4677,4627,3396,7217,1697,6257,7817,9508,1498,0458,41332,41933,95833,8027,6947,4897,7987,695
       Intangible Assets 
8,467
8,303
7,680
7,585
98,718
95,978
94,291
91,157
88,986
87,084
85,021
82,382
80,436
78,490
76,545
74,599
72,653
70,707
68,762
4,626
4,297
3,969
3,081
3,0813,9694,2974,62668,76270,70772,65374,59976,54578,49080,43682,38285,02187,08488,98691,15794,29195,97898,7187,5857,6808,3038,467
       Long-term Assets Other 
4,003
4,884
5,761
7,478
27,507
13,451
13,226
15,420
20,292
18,748
23,671
20,285
20,385
20,914
18,342
17,219
18,131
19,390
18,951
18,672
17,571
19,524
11,310
11,31019,52417,57118,67218,95119,39018,13117,21918,34220,91420,38520,28523,67118,74820,29215,42013,22613,45127,5077,4785,7614,8844,003
> Total Liabilities 
37,588
36,418
37,897
42,332
105,219
152,081
131,887
93,205
85,597
76,327
62,870
60,450
56,452
67,970
62,809
63,565
61,486
54,867
57,672
58,367
55,208
52,317
51,541
51,54152,31755,20858,36757,67254,86761,48663,56562,80967,97056,45260,45062,87076,32785,59793,205131,887152,081105,21942,33237,89736,41837,588
   > Total Current Liabilities 
11,602
10,388
11,195
16,277
26,188
27,907
31,139
36,867
46,973
41,367
28,771
29,795
26,992
29,431
26,352
27,914
28,693
23,456
28,064
31,059
28,460
26,121
25,493
25,49326,12128,46031,05928,06423,45628,69327,91426,35229,43126,99229,79528,77141,36746,97336,86731,13927,90726,18816,27711,19510,38811,602
       Accounts payable 
3,571
2,287
2,702
3,832
9,906
6,162
6,800
8,984
8,683
8,101
7,942
7,633
7,444
8,165
8,353
9,074
8,948
7,944
8,251
9,860
10,022
9,994
6,805
6,8059,99410,0229,8608,2517,9448,9489,0748,3538,1657,4447,6337,9428,1018,6838,9846,8006,1629,9063,8322,7022,2873,571
       Other Current Liabilities 
0
0
0
0
4,303
0
0
13,090
24,830
16,870
5,984
4,315
4,315
4,315
0
0
0
0
0
0
0
517
378
37851700000004,3154,3154,3155,98416,87024,83013,090004,3030000
   > Long-term Liabilities 
25,986
26,030
26,702
26,055
79,031
124,174
100,748
56,338
38,624
34,960
34,099
30,655
29,460
38,539
36,457
35,651
32,793
31,411
29,608
27,308
26,748
26,196
26,048
26,04826,19626,74827,30829,60831,41132,79335,65136,45738,53929,46030,65534,09934,96038,62456,338100,748124,17479,03126,05526,70226,03025,986
       Capital Lease Obligations Min Short Term Debt
23,307
23,075
22,712
22,508
23,426
23,076
22,758
22,464
22,179
21,604
21,180
20,954
20,470
29,732
29,183
30,890
30,385
29,860
29,307
29,037
28,473
28,076
27,534
27,53428,07628,47329,03729,30729,86030,38530,89029,18329,73220,47020,95421,18021,60422,17922,46422,75823,07623,42622,50822,71223,07523,307
       Long-term Liabilities Other 
366
373
372
357
41,270
37,905
42,032
23,564
7,343
1,780
1,489
1,258
684
587
474
398
399
401
400
404
404
407
806
8064074044044004013993984745876841,2581,4891,7807,34323,56442,03237,90541,270357372373366
> Total Stockholder Equity
269,071
250,946
281,682
288,378
293,694
288,444
284,451
272,400
276,656
286,804
290,060
287,085
285,787
286,153
284,937
285,563
277,588
274,015
270,486
212,265
208,536
210,338
179,864
179,864210,338208,536212,265270,486274,015277,588285,563284,937286,153285,787287,085290,060286,804276,656272,400284,451288,444293,694288,378281,682250,946269,071
   Common Stock00000000000000000000000
   Retained Earnings 
222,740
232,175
241,375
245,426
251,219
243,511
237,100
221,444
224,282
230,813
231,371
225,578
222,645
219,802
215,627
210,719
200,369
197,628
191,052
128,052
123,538
123,450
93,532
93,532123,450123,538128,052191,052197,628200,369210,719215,627219,802222,645225,578231,371230,813224,282221,444237,100243,511251,219245,426241,375232,175222,740
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 00000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue166,662
Cost of Revenue-63,574
Gross Profit103,088103,088
 
Operating Income (+$)
Gross Profit103,088
Operating Expense-192,111
Operating Income-25,449-89,023
 
Operating Expense (+$)
Research Development32,690
Selling General Administrative95,847
Selling And Marketing Expenses0
Operating Expense192,111128,537
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-2,312
Net Interest Income2,312
 
Pretax Income (+$)
Operating Income-25,449
Net Interest Income2,312
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-85,32736,741
EBIT - interestExpense = 0
-82,667
-82,667
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-85,327
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-85,327
Tax Provision--2,660
Net Income From Continuing Ops-82,667-82,667
Net Income-82,667
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-62,190-2,312
 

Technical Analysis of ANIKA THERAPEUTICS (AKP.SG)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ANIKA THERAPEUTICS (AKP.SG). The general trend of ANIKA THERAPEUTICS (AKP.SG) is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ANIKA THERAPEUTICS (AKP.SG)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ANIKA THERAPEUTICS (AKP.SG).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.30 < 17.00 < 17.10.

The bearish price targets are: 14.90 > 14.80 > 14.70.

Tweet this
ANIKA THERAPEUTICS (AKP.SG) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ANIKA THERAPEUTICS (AKP.SG). The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ANIKA THERAPEUTICS (AKP.SG) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Moving Average Convergence/Divergence (MACD) ChartANIKA THERAPEUTICS (AKP.SG) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ANIKA THERAPEUTICS (AKP.SG). The current adx is .

ANIKA THERAPEUTICS (AKP.SG) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Relative Strength Index (RSI) ChartANIKA THERAPEUTICS (AKP.SG) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Stochastic Oscillator ChartANIKA THERAPEUTICS (AKP.SG) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Commodity Channel Index (CCI) ChartANIKA THERAPEUTICS (AKP.SG) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Chande Momentum Oscillator (CMO) ChartANIKA THERAPEUTICS (AKP.SG) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Williams %R ChartANIKA THERAPEUTICS (AKP.SG) Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Average True Range (ATR) ChartANIKA THERAPEUTICS (AKP.SG) Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily On-Balance Volume (OBV) ChartANIKA THERAPEUTICS (AKP.SG) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ANIKA THERAPEUTICS (AKP.SG).

ANIKA THERAPEUTICS (AKP.SG) Daily Money Flow Index (MFI) ChartANIKA THERAPEUTICS (AKP.SG) Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ANIKA THERAPEUTICS (AKP.SG).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

ANIKA THERAPEUTICS (AKP.SG) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ANIKA THERAPEUTICS (AKP.SG) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose14.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of ANIKA THERAPEUTICS (AKP.SG) with someone you think should read this too:
  • Are you bullish or bearish on ANIKA THERAPEUTICS (AKP.SG)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ANIKA THERAPEUTICS (AKP.SG)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ANIKA THERAPEUTICS (AKP.SG)

I send you an email if I find something interesting about ANIKA THERAPEUTICS (AKP.SG).


Comments

How you think about this?

Leave a comment

Stay informed about ANIKA THERAPEUTICS (AKP.SG).

Receive notifications about ANIKA THERAPEUTICS (AKP.SG) in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.